The DOI matches its Crossref record; 36 of the 40 references it cites were found in a registry or an index.
Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus
Open accessAbstract
Background & aims Information on the clinical profile of pancreatic cancer (PaC) associated diabetes (DM) is limited. We compared the prevalence and clinical characteristics of DM in subjects with and without PaC.Methods We prospectively recruited 512 newly diagnosed PaC cases and 933 controls of similar age, who completed demographic and clinical questionnaires and had fasting blood glucose (FBG) levels measured at recruitment and after pancreaticoduodenectomy (n = 105). Subjects with a FBG level >126 mg/dL or who were on antidiabetic treatment were classified as having DM.Results DM was more prevalent (47% vs 7%; P < .001) and predominantly of new onset (<2-year duration) (74% vs 53%; P = .002) among cases compared with controls. Among PaC cases, those with DM (n = 243) were older (68 +/- 10 vs 64 +/- 12 years; P < .001), reported higher usual adult body mass index (30 +/- 6 vs 27 +/- 5 kg/m(2); P < .001), and had a greater frequency of family history of DM (47% vs 31%; P < .001) compared with those without DM (n = 269). After pancreaticoduodenectomy, while DM resolved in 17 of 30 patients (57%) with new-onset DM, its prevalence was unchanged in patients with long-standing DM (n = 11) (P = .009).Conclusions PaC is a powerful diabetogenic state; DM associated with PaC is often new-onset, resolves following cancer resection, and appears to be associated with conventional risk factors for DM. New-onset DM in patients with PaC is likely induced by the tumor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When diagnosed with pancreatic ductal adenocarcinoma, around 80% of patients have abnormal fasting glucose or glucose intolerance.49,50”
From Early detection of pancreatic cancer (2020) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Unwin, N. C. (2006) · Cited by 1,661
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citationDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/dc07-s042 · Cited by 574
Chari, S. T., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J. E., de Andrade, M., & Petersen, G. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.040 · Cited by 519
Self-citationDiabetes and the Risk of Pancreatic Cancer
Gullo, L., Pezzilli, R., & Morselli‐Labate, A. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310203 · Cited by 366
Seiler, C., Wagner, M., Bachmann, T., Redaelli, C., Schmied, B. M., Uhl, W. H., Frieß, H., & Büchler, M. W. (2005) · British journal of surgery · doi:10.1002/bjs.4881 · Cited by 254
Cited by
Sorted by citations
Items 401–500 of 621
Research on the relationships between pancreatic cancer and hyperglycemia in C hinese populations
Huang, S., Ye, H., Wu, W., Chen, C., Li, J., Fu, D., & Li, Y. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00237.x · Cited by 4
Pancreatic Cancer Heralded by Worsening Glycemic Control: A Report of Two Cases
Desai, D., Rao, D., Sukrithan, V., Weinstein, E., Goyal, A., & Schubart, U. K. (2017) · Journal of Investigative Medicine High Impact Case Reports · doi:10.1177/2324709617714286 · Cited by 4
New onset diabetes as a clue for early diagnosis of pancreatic cancer
Vincenzi, B., & D’Onofrio, L. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3033 · Cited by 4
Diabetes and Pancreatic Cancer: A Bidirectional Relationship Perspective
Gupta, M. K., Sarojamma, V., & Vadde, R. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_3 · Cited by 4
Egleston, B. L., Bai, T., Bleicher, R. J., Taylor, S. J., Lutz, M. H., & Vučetić, S. (2020) · Biometrics · doi:10.1111/biom.13338 · Cited by 6
Hempel, S., Oehme, F., Ehehalt, F., Solimena, M., Kolbinger, F. R., Bogner, A., Welsch, T., Weitz, J., & Distler, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030663 · Cited by 4
Michálková, L., Horník, Š., Sýkora, J., Setnička, V., & Bunganič, B. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00047 · Cited by 4
Hasibuzzaman, M. A., Alam, H. I., Mia, M. A. R., Islam, S., Sultana, S., Ahmed, S., Masud, A., Rahman, S., Khan, A. A., Rimti, F. H., et al. (2023) · Journal of Advanced Biotechnology and Experimental Therapeutics · doi:10.5455/jabet.2023.d145 · Cited by 4
Barreto, S. G., Michael, M., & Keating, D. J. (2020) · Pancreatology · doi:10.1016/j.pan.2020.02.001 · Cited by 4
Macgregor‐Das, A. M., & Goggins, M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_56 · Cited by 4
Diabetes in Pancreatitis, Pancreatectomy and Other Pancreatic Diseases
Tiengo, A., de Kreutzenberg, S. V., & Prato, S. D. (2014) · Frontiers in diabetes · doi:10.1159/000357252 · Cited by 4
Steiner, E., Kazianka, L., Breuer, R., Hacker, M., Wadsak, W., Mitterhauser, M., Stimpfl, T., Reiter, B., Karanikas, G., & Miholic, J. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3451-0 · Cited by 4
Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer
Stern, J. H., Arriaga, Y. E., Gupta, A., Verma, U. N., Karri, S., Syed, S. K., Khosama, L., Mansour, J. C., Meyer, J., Scherer, P. E., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001208 · Cited by 4
Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes?
Mejza, M., Bajer, A., Wanibuchi, S., & Małecka-Wojciesko, E. (2025) · Biomedicines · doi:10.3390/biomedicines13040836 · Cited by 3
Kubo, H., Ohgi, K., Otsuka, S., Okawa, Y., Ashida, R., Yamada, M., Kato, Y., Dei, H., Uesaka, K., Notsu, A., et al. (2025) · Annals of Surgery Open · doi:10.1097/as9.0000000000000597 · Cited by 3
Muscle strength and mass as predictors of pancreatic cancer: insights from the UK biobank
Liu, X., Song, H., Li, C., Hu, X., Li, C., Lu, G., Xiang, H., & Yu, Q. (2025) · BMC Cancer · doi:10.1186/s12885-025-14766-w · Cited by 3
Verhoeff, K. K., & Shapiro, A. M. J. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101414 · Cited by 3
Pancreatic Cancer and Diabetes: Insights, Hypotheses, and Next Steps
Hill, J. L. E., Hill, T. G., Parslow, D., & Hill, D. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110245 · Cited by 4
Adavikolanu, K. R., Ramalingam, C., Balan, K. S., Raghava, K. S. A., Manish, K., Divya, K. N., Ambedkar, Y. R., Babu, V. S., & Kumar, K. A. (2025) · Oncoscience · doi:10.18632/oncoscience.637 · Cited by 3
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System
Khalaf, N. I., Kramer, J. R., Liu, Y., Abrams, D., Singh, H., El‐Serag, H. B., & Kanwal, F. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08035-8 · Cited by 3
Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case–Control Study
Grewe, S., Jördens, M. S., Roderburg, C., Leyh, C., Labuhn, S., Luedde, T., Krieg, S., Krieg, A. H., Loosen, S. H., & Kostev, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185584 · Cited by 3
Le diabète associé au cancer du pancréas est un diabète paranéoplasique
Paepegaey, A. C., & Fève, B. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30056-6 · Cited by 3
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_6 · Cited by 3
Ohata, K., FUJII, H., Sadaka, S., Kato‐Hayashi, H., Iihara, H., Kobayashi, R., Uemura, S., Iwashita, T., Shimizu, M., & Suzuki, A. (2021) · Anticancer Research · doi:10.21873/anticanres.15154 · Cited by 3
Aggarwal, G., & Chari, S. T. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1623-5_62 · Cited by 3
Self-citationIncreased alpha cell to beta cell ratio in patients with pancreatic cancer
Tsuchiya, T., Saisho, Y., Inaishi, J., Sasaki, H., Sato, M., Nishikawa, M., Masugi, Y., Yamada, T., & Itoh, H. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0170 · Cited by 3
Identification of the Genetic Association Between Type-2-Diabetes and Pancreatic Cancer
Liang, Y., Chen, W., Tang, Y., & Chen, M. (2022) · Biochemical Genetics · doi:10.1007/s10528-022-10308-2 · Cited by 4
Pretta, A., Ziranu, P., Giampieri, R., Donisi, C., Cimbro, E., Spanu, D., Lai, E., Pecci, F., Balconi, F., Lupi, A., et al. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.11.012 · Cited by 3
Huang, Y., Zhang, W., Xu, C., Li, Q., Zhang, W., Xu, W., & Zhang, M. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003196 · Cited by 3
Zhu, X., Xiao, Z., Liu, H., Zhang, P., Deng, S., Ding, L., Feng, J., Luo, J., Ni, Q., Luo, G., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000006168 · Cited by 3
Liao, W. (2023) · Journal of Cancer Research and Practice · doi:10.4103/ejcrp.ejcrp-d-23-00002 · Cited by 3
New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype
Trembath, H. E., LaBella, M. E., Kearney, J. F., Hariharan, A., Zarmer, S., Nabors, M., McCabe, I. C., Zhao, R. T., Meyers, M. O., Kim, H. J., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.28044 · Cited by 3
Zhao, X., Wang, Y., Zhou, L., Ye, A., & Zhu, Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-85807-4 · Cited by 3
Solaiyappan, M., Bharti, S. K., Sharma, R. K., Dbouk, M. H., Nizam, W., Brock, M. V., Goggins, M., & Bhujwalla, Z. M. (2025) · Communications Medicine · doi:10.1038/s43856-024-00727-0 · Cited by 3
Development of Novel Diagnostic Pancreatic Tumor Biomarkers
Oldfield, L. S., Rao, R. G., Barrera, L. N., & Costello, E. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_86 · Cited by 3
Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics
Layeghi‐Ghalehsoukhteh, S., Choudhuri, S. P., Ocal, O., Zolghadri, Y., Pashkov, V., Niederstrasser, H., Posner, B. A., Kantheti, H. S., Azevedo‐Pouly, A. C. P., Huang, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77373-8 · Cited by 3
Mauro, L. A., Herman, J. M., Jaffee, E. M., & Laheru, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00081-3 · Cited by 3
Glycemic Abnormalities in Pancreatic Cystic Lesions—A Single-Center Retrospective Analysis
Balaban, D. V., Coman, L. I., Balaban, M., Zoican, A., Pușcașu, D. A., Ayatollahi, S., Mihălțeanu, E., Costache, R. S., Radu, F. I., & Jinga, M. (2023) · Gastroenterology Insights · doi:10.3390/gastroent14020015 · Cited by 2
Mellenthin, C., Meier, C. R., Jick, S. S., Bühler, L. H., Adamina, M., & Schneider, C. (2025) · Pancreatology · doi:10.1016/j.pan.2025.09.017 · Cited by 4
Tao, L. V., Karasinska, J. M., Souza, V. G. P., Loree, J. M., Johnson, J. D., Renouf, D. J., & Schaeffer, D. F. (2026) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2025.1645459 · Cited by 3
Lee, M., Yu, M. H., Chae, W., Lee, Y., Lee, B. I., Kang, E. S., Cha, B., Jang, S., & Chung, M. J. (2026) · Gut · doi:10.1136/gutjnl-2025-335863 · Cited by 2
Distal Enteral Feeding Helps Blood Sugar Control in Pancreatectomized Patients
Wu, J., Yang, C., Kuo, T., Lai, H., Chiang, P., Hsieh, S., & Tien, Y. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3157-7 · Cited by 2
Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer
Göß, R., Mutgan, A. C., Çalışan, U., Erdogan, Y. C., Ren, L., Jäger, C., Safak, O., Stupakov, P., Istvánffy, R., Frieß, H., et al. (2021) · Cancers · doi:10.3390/cancers13020249 · Cited by 2
Wiseman, J. T., Chakedis, J. M., Beal, E. W., Paredes, A. Z., McElhany, A. L., Fang, A. M., Manilchuk, A., Ellison, C., Buren, G. V., Pawlik, T. M., et al. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-05014-0 · Cited by 2
Acute pancreatitis as an early sign of pancreatic cancer; a retrospective, matched cohort study
Cho, S.-H., Lee, Y., Huh, G., Jeong, H., Yoo, C., Jun, S. T., Seo, D. W., & Oh, D. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2414804 · Cited by 2
Diabetic ketoacidosis as first presentation of undiagnosed pancreatic cancer in an octogenarian
Le, M. V., Fourlanos, S., & Barmanray, R. (2024) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-23-0145 · Cited by 2
Screening for pancreatic ductal adenocarcinoma in the population with diabetes
Sharp, P. S., Brown, B., & Price, H. C. (2021) · Practical Diabetes · doi:10.1002/pdi.2319 · Cited by 2
Risk Factors in Pancreatic Cancer
Seicean, A., & Seice, R. (2012) · InTech eBooks · doi:10.5772/27107 · Cited by 2
Role of genetic testing in hereditary melanoma
Kohlmann, W. K., Dunn, K., & Leachman, S. A. (2008) · Expert Review of Dermatology · doi:10.1586/17469872.3.6.639 · Cited by 2
Pancreatic cancer: early detection, diagnosis, and screening
Suzuki, R., Ohira, H., Irisawa, A., & Bhutani, M. S. (2012) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-012-0327-0 · Cited by 2
Swislocki, A. (2021) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0070 · Cited by 2
Development of Novel Pancreatic Tumor Biomarkers
Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_50 · Cited by 2
Usefulness of Practitioner-Led Pancreatic Cancer Screening
Matsumoto, K., Kushiyama, Y., Izumi, A., Ohnishi, K., Miura, M., Ohuchi, Y., Hori, I., Nakamura, T., Hori, K., Koshino, K., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12092257 · Cited by 2
Diabetes Mellitus and Early Detection of Pancreatic Cancer
Fu, Y.-B., Yang, G., Qiu, J., & Zhang, T. (2022) · Cancer Screening and Prevention · doi:10.14218/csp.2022.00013 · Cited by 3
Diabetogenic liver metastasis from pancreatic cancer: a case report
Kiritani, S., Ono, Y., Takamatsu, M., Oba, A., Sato, T., Ito, H., Inoue, Y., & Takahashi, Y. (2022) · Surgical Case Reports · doi:10.1186/s40792-022-01582-8 · Cited by 2
Pancreatic Cancer: Nanoparticle Targeted Therapy Via Epidermal Growth Factor Receptor
Dwivedi, V., Sameem, S., Rahman, M., Pathak, P., & Verma, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-5558-7_6 · Cited by 2
Chen, G., Zhang, R., Tan, C., Liu, X., Yu, L., & Chen, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1208187 · Cited by 2
Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer
Sakin, A., Şahin, S., Sakin, A., Atçı, M. M., Geredeli, Ç., & Cihan, Ş. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.840948 · Cited by 2
Chari, S. T., Singh, D. P., Aggarwal, G., & Petersen, G. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_79 · Cited by 2
Self-citationDiabetes mellitus as a result of pancreatic cancer
Hart, P. A. (2015) · doi:10.3998/panc.2015.34 · Cited by 2
New‐onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible?
Andersen, D. K., Chari, S. T., Costello, E., Crnogorac‐Jurcevic, T., Hart, P. A., Maitra, A., & Pandol, S. J. (2021) · Wiley eBooks · doi:10.1002/9781119570097.ch51 · Cited by 2
Self-citationPita-Grisanti, V., Dubay, K., Lahooti, A., Badi, N., Ueltschi, O., Gumpper, K., Hsueh, H., Lahooti, I., Chavez-Tomar, M., Terhorst, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.521203 · Cited by 2
Hemoglobin A1c as a Marker to Stratify Diabetes Risk Following Pancreaticoduodenectomy
Bleicher, J. M., Shepherd, H. M., & Scaife, C. L. (2019) · Surgery Open Science · doi:10.1016/j.sopen.2020.01.001 · Cited by 1
Xu, T., Dillon, J. S., Quelle, D. E., Nash, S. H., Cho, H. R., & O’Rorke, M. A. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-25-0155 · Cited by 1
Hariri, H. M., Wahab, S. A., Johnston, M. E., Surapaneni, S., Pratt, C. G., Szu-Aun, L., Hanseman, D. J., Ahmad, S. A., Patel, S. H., & Wilson, G. C. (2025) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2025.116482 · Cited by 1
Early Detection of Pancreatic Cancer: Recent Advancements
Konikoff, T. D., & Majumder, S. (2025) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-025-00480-w · Cited by 2
Li, Y., Xiang, S., Zhong, W., Wang, S., Zhang, S., Zhang, J., Du, Y., Wang, C., & Che, X. (2025) · Pancreatology · doi:10.1016/j.pan.2025.11.004 · Cited by 1
Sex disparities in bladder cancer diagnosis: evidence from the UK Biobank
Shweiki, D. (2025) · World Journal of Urology · doi:10.1007/s00345-025-06120-3 · Cited by 1
Schrader, S., Rafiq, M., Martínez-Gutiérrez, J., Waterhouse, M. A., Lee, B., Neale, R. Ε., & Emery, J. D. (2026) · British Journal of General Practice · doi:10.3399/bjgp.2025.0328 · Cited by 1
Cystic lesions and their role in pancreatic cancer risk stratification
Lyons, R. G., Maher, S. G., & Lysaght, J. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102704 · Cited by 1
Maitra, A., Chari, S. T., Wu, B., Eeden, S. K. V. D., Fisher, W., Vege, S. S., Rinaudo, J. A., Ziding, F., Hart, P. A., Brand, R. E., et al. (2026) · Pancreatology · doi:10.1016/j.pan.2026.04.020 · Cited by 1
Self-citationHuang, K., Huang, Z., He, Y., Zhao, P., & Hu, X. (2026) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70205 · Cited by 1
Diabetes mellitus y cáncer de páncreas
Anillo, C. M., Ruiz, M. G., González, N. O., & Valle, H. A. (2011) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2011.03.007 · Cited by 1
Kemp, T. (2010) · UpSpace Institutional Repository (University of Pretoria) · Cited by 1
Diabetes mellitus as an early symptom of pancreatic cancer diagnosed three years later
Slim, I., Koussay, A. C. H., Chefii, R., Trimech-Ajmi, S., Landolsi, A., Chadli-Chaieb, M., Maaroufi-Beizig, A., & Chaieb, L. (2008) · Annales d Endocrinologie · doi:10.1016/j.ando.2008.09.006 · Cited by 1
Review Article New perceptions of interrelationship between pancreatic cancer and diabetes
Pang, W., & Yuan, Y. (2014) · Cited by 1
Cancer du pancréas exocrine : clinique, bilan diagnostique et préthérapeutique
Buffet, C. (2009) · EMC - Hépatologie · doi:10.1016/s1155-1976(09)48138-5 · Cited by 1
Pancreatic Cancer in a Northern African Population: A Retrospective Analysis Spanning Two Decades
Sellam, F., Mrabent, N. M., Harir, N., Khaled, M. B., Salah, R., Diaf, M., & Tou, A. (2015) · JOP, journal of the pancreas · Cited by 1
Risk factors for pancreatic cancer in patients with chronic pancreatitis
Rajesh, G., Girish, B. N., Panicker, S., Venu, R. P., & Balakrishnan, V. (2016) · Tropical Gastroenterology · doi:10.7869/tg.352 · Cited by 1
Development of Novel Diagnostic Pancreatic Tumor Biomarkers 2nd ed
Oldfield, L. S., Rao, R. G., Barrera, L. N., & Costello, E. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_86-1 · Cited by 1
Hideyuki, I. M. A. I., Ohike, N., Norose, T., Isobe, T., Fujimasa, K., Nagahama, M., Tanaka, J., Nagasaka, S., & Takimoto, M. (2018) · The Showa University Journal of Medical Sciences · doi:10.15369/sujms.30.341 · Cited by 1
Insulin Resistance Is a Common Core Tethered to Diabetes and Pancreatic Cancer Risk
Verma, H. K., & Bhaskar, L. V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_12 · Cited by 1
Zhou, L., & Kang, M. (2017) · PubMed Central · Cited by 1
The Screening and Early Detection of Pancreatic Cancer: Who, When, and How?
Chang, J. H. (2020) · The Korean Journal of Pancreas and Biliary Tract · doi:10.15279/kpba.2020.25.2.65 · Cited by 1
Risk Factors for Pancreatic Cancer
Franklin, O., & Sund, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_1 · Cited by 1
Chari, S. T., Singh, D. P., Aggarwal, G., & Petersen, G. M. (2021) · Springer eBooks · doi:10.1007/978-3-319-90761-1_79-1 · Cited by 1
Self-citationSecondary Screening for Inherited Pancreatic Ductal Adenocarcinoma
Sheel, A., Nicholson, J., Sarantitis, I., Neoptolemos, J. P., & Greenhalf, W. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_63 · Cited by 1
Pancreatic Cancer and Diabetes Mellitus
Chari, S. T., & Khan, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_3 · Cited by 1
Self-citationDifferent post-pancreatectomy glucagon responses to a meal test between surgical approaches
Matsuda, T., Himeno, N., Nakashima, A., Nakagawa, N., Kohashi, T., Kawamori, D., & Kamei, N. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0032 · Cited by 1
Kiritani, S., Ono, Y., Takamatsu, M., Yoshio, S., Miyashita, M., Oba, A., Sato, T., Ito, H., Inoue, Y., Saiura, A., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-14408-0 · Cited by 1
A journey to and with the stars: The pancreatic stellate cell story
Apte, M. V. (2023) · Pancreatology · doi:10.1016/j.pan.2023.10.024 · Cited by 1
Watabe, H., Yasumura, K., Fukai‐Watabe, S., & Watabe, T. (2024) · Sonography · doi:10.1002/sono.12420 · Cited by 1
Unusual Manifestations of Primary Pancreatic Neoplasia
Włoszek, E., Krupa, K., Fudalej, M. M., Miski, H., Badowska-Kozakiewicz, A. M., & Deptała, A. (2025) · Cancers · doi:10.3390/cancers17193240 · Cited by 1
New-onset Diabetes as an Early Sign of Pancreatic Cancer
Ahn, J., & Lee, J. K. (2013) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2013.62.5.263 · Cited by 1
Li, J. H., Tang, C. J., & Hennessey, J. V. (2016) · Case Reports in Internal Medicine · doi:10.5430/crim.v3n4p22 · Cited by 1
Metabolische Entgleisungen als paraneoplastische Syndrome
Krug, S., & Michl, P. (2017) · Der Internist · doi:10.1007/s00108-017-0357-2 · Cited by 1
Screening for Pancreatic Cancer in Individuals With New-onset Diabetes Mellitus
Lo, T. (2018) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2018.07.010 · Cited by 1
Nakeeb, A. E., Shehta, A., Said, R., Dosoky, M. E., Moneer, A., Elrefai, M., Hamed, H., & Abdallah, T. (2018) · Surgery Gastroenterology and Oncology · doi:10.21614/sgo-23-5-342 · Cited by 1
Metabolic Biomarkers of Pancreatic Cancer
Mahajan, U. M., Li, Q., Kamlage, B., Lerch, M. M., & Mayerle, J. V. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_5 · Cited by 1
Kalantari, S., Pourshams, A., Roudi, R., Zali, H., Bandehpour, M., Kalantari, A., Ghanbari, R., D’Angelo, A., Kazemi, B., & Madjd, Z. (2021) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_122_21 · Cited by 1
Metadata
- Authors
- Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Chari, Suresh T.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 134
- Issue
- 4
- Pages
- 981-987
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC2323514
- OpenAlex
- W1998608669
- Cited by
- 621
- References
- 40
- Citations by year
- 2026: 25 · 2025: 45 · 2024: 32 · 2023: 50 · 2022: 40 · 2021: 59 · 2020: 47 · 2019: 42 · 2018: 39 · 2017: 36 · 2016: 20 · 2015: 29 · 2014: 35 · 2013: 26 · 2012: 38
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50 CA 10270, P50CA102701, R01CA100685)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- pancreatic cancer, diabetes mellitus, new-onset diabetes, pancreaticoduodenectomy, fasting blood glucose, body mass index, family history of diabetes, diabetes risk factors, cancer-associated diabetes
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Neoplasm Staging, Pancreatic Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, United States, Prevalence, Pancreaticoduodenectomy, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review